Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers

  • 102 Accesses

  • 26 Citations

Summary

The effects of single oral doses of ketoconazole 400 mg and terbinafine 500 mg on the hepatic microsomal system have been investigated in 8 healthy male volunteers. Microsomal activity caffeine was assessed by following the metabolism of 3 mg/kg bodyweight i.v. administered 1 h after the drug.

The inhibitory effect of terbinafine was more pronounced than that of ketoconazole: clearance was decreased from 1.34 ml·kg−1·min−1 in controls to 1.06 and 1.21 ml·kg−1·min−1, respectively, and the corresponding half-life was increased from 5.8 h in controls to 7.6 and 6.7 h, respectively. The apparent volume of distribution remained unchanged. The serum levels of the antimycotics were within the therapeutic range in each subject.

Although all three substances are metabolised by microsomes, the kinetic parameters (Cmax, half-life, elimination constant) of the antimycotics were poorly if at all correlated with the elimination of caffeine.

This is a preview of subscription content, log in to check access.

References

  1. Arnaud MJ, Welsch C (1981) Theophylline and caffeine metabolism in man. In: Rietbrook N, Woodcock BG, Staib AH (eds) Theophylline and other methylxanthines. Vieweg und Sohn Braunschweig Wiesbaden, pp 135–148

  2. Battig FA, Nefzger M, Schulz G (1987) Major biotransformation routes of some allylamine antimycotics. In: Fromtling RA (ed) Recent trends in the discovery, development and evaluation of antifungal agents. JR Prous Science Publishers, Barcelona, pp 479–495

  3. Baxter JG, Brass C, Schentag J, Slaughter RL (1986) Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs. J Pharm Sci 75: 443–447

  4. Broughton LJ, Rogers HJ (1981) Decreased systemic clearance of caffeine due to cimetidine. Br J Clin Pharmacol 12: 155–159

  5. Brown MW, Maldonado AL, Meredith CG, Speeg KV (1985) Effect of ketoconazole on hepatic oxidative drug metabolism. Clin Pharmacol Ther 37: 290–297

  6. Campbell ME, Grant GM, Inaba T, Kalow W (1987) Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Drug Metab Dispos 15: 237–249

  7. DeCoster R, Caers I, Haelterman C, Debroye M (1985) Effect of a single administration of ketoconazole on total and physiologically free plasma testosteron and 17β-oestradiol levels in healthy male volunteers. Eur J Clin Pharmacol 29: 489–493

  8. Gumbleton M, Brown JE, Hawksworth G, Whiting PH (1985) The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity. Transplantation 40: 454–455

  9. Hawksworth G, Brown JE, Burke MD, Tan K (1986) Inhibition of antipyrine metabolite formation by ketoconazole in rat and in human hepatic microsomes. Biochem Soc Trans 14: 918–919

  10. Joeres R, Klinker H, Heusler H, Epping J, Richter E (1987) Influence of mexiletine on caffeine elimination. Pharmacol Ther 33: 163–169

  11. Lewis JH, Zimmerman HJ, Benson GD, Ishak KI (1984) Hepatic injury associated with ketoconazole therapy. Gastroenterology 86: 503–513

  12. Lin JH, Chremos AN, Chiou R, Yeh KC, Williams R (1987) Comparative effects of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers. Br J Clin Pharmacol 24: 669–672

  13. Meredith CG, Maldonado AL, Speeg KV (1985) The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro. Drug Metab Dispos 13: 156–162

  14. Pascucci VL, Bennett J, Narang PK, Chatterji DC (1983) Quantification of ketoconazole in biological fluids using high-performance liquid chromatography. J Pharm Sci 72: 1467–1469

  15. Petranyi G, Ryder NS, Stütz A (1984) Allylamine derivatives: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 224: 1239–1241

  16. Ryder NS (1984) Selective inhibition of squalene epoxidation by allylamine antimycotic agents. Micr Cell Wall Syn Autolysis 7: 313–321

  17. Schatz F, Haberl H (1989) Arzneimittelforsch/Drug Res (in press)

  18. Schatz F, Millendorfer A, Czok R (1987) Pharmacokinetics of orally applied terbinafine in man. In: Berkarda B (ed) Proc. 15th Int. Congr. Chemotherapy, vol 1. Kümmerle, Munich Tokyo Shanghai, pp 417–419

  19. Schürmeyer Th, Nieschlag E (1984) Effect of ketoconazole and other imidazole fungizides on testosterone biosynthesis. Acta Endocrinol 105: 275–280

  20. Schuster I (1985) The interaction of representative members from two classes of antimycotics — the azoles and the allylamines — with cytochromes P-450 in steroidogenic tissues and liver. Xenobiotica 15: 529–546

  21. Staib AH, Harder S, Mieke S, Beer C, Stille W (1987) Gyraseinhibitors impair caffeine elimination in man. Methods Find Exp Clin Pharmacol 9: 193–198

  22. van Tyle JH (1984) Ketoconazole. Pharmacotherapy 4: 343–373

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wahlländer, A., Paumgartner, G. Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers. Eur J Clin Pharmacol 37, 279–283 (1989). https://doi.org/10.1007/BF00679784

Download citation

Key words

  • ketoconazole
  • terbinafine
  • microsomal metabolism
  • caffeine
  • male volunteers
  • pharmacokinetics
  • drug interaction
  • cytochrome P-450